# Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

> **NCT04106830** · — · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- NMO Spectrum Disorder
- MRI
- Multiple Sclerosis
- MOGAD

## Interventions

- **DRUG:** Intravenous steroid

## Key facts

- **NCT ID:** NCT04106830
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04106830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04106830, "Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04106830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*